2013 Q4 Form 10-K Financial Statement

#000110465914024455 Filed on March 31, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue $7.540M $30.79M $8.040M
YoY Change -6.22% -8.5% 31.59%
Cost Of Revenue $5.070M $20.48M $6.390M
YoY Change -20.66% -8.87% 27.29%
Gross Profit $2.480M $10.31M $1.650M
YoY Change 50.3% -7.75% 51.38%
Gross Profit Margin 32.89% 33.49% 20.52%
Selling, General & Admin $3.640M $15.40M $3.930M
YoY Change -7.38% 8.15% 3.69%
% of Gross Profit 146.77% 149.41% 238.18%
Research & Development $190.0K $837.1K $270.0K
YoY Change -29.63% -3.99% -3.57%
% of Gross Profit 7.66% 8.12% 16.36%
Depreciation & Amortization $320.0K $1.284M $350.0K
YoY Change -8.57% -3.86% 9.38%
% of Gross Profit 12.9% 12.46% 21.21%
Operating Expenses $3.830M $16.24M $4.200M
YoY Change -8.81% 7.45% 3.45%
Operating Profit -$1.350M -$5.931M -$2.550M
YoY Change -47.06% 50.58% -14.14%
Interest Expense -$50.00K $230.6K -$10.00K
YoY Change 400.0% -0.27% -75.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.400M -$6.123M -$2.560M
YoY Change -45.31% 48.5% -15.23%
Income Tax $30.00K $90.97K -$20.00K
% Of Pretax Income
Net Earnings -$1.650M -$6.214M -$2.770M
YoY Change -40.43% 50.35% -5.14%
Net Earnings / Revenue -21.88% -20.18% -34.45%
Basic Earnings Per Share -$0.26
Diluted Earnings Per Share -$0.06 -$0.26 -$0.10
COMMON SHARES
Basic Shares Outstanding 26.97M shares 27.00M shares
Diluted Shares Outstanding 27.00M shares

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.63M $27.63M $25.96M
YoY Change 6.43% 6.43% 1.13%
Cash & Equivalents $27.63M $27.63M $25.96M
Short-Term Investments
Other Short-Term Assets $1.066M $1.070M $783.8K
YoY Change 35.97% 37.18% 258.65%
Inventory $5.736M $5.740M $4.990M
Prepaid Expenses
Receivables $3.477M $3.480M $3.694M
Other Receivables $0.00 $0.00 $10.00K
Total Short-Term Assets $37.91M $37.91M $35.44M
YoY Change 6.96% 6.97% -1.29%
LONG-TERM ASSETS
Property, Plant & Equipment $10.91M $10.91M $11.90M
YoY Change -8.32% -8.32% -5.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $11.19M $11.19M $12.19M
YoY Change -8.21% -8.2% -6.34%
TOTAL ASSETS
Total Short-Term Assets $37.91M $37.91M $35.44M
Total Long-Term Assets $11.19M $11.19M $12.19M
Total Assets $49.10M $49.10M $47.63M
YoY Change 3.08% 3.09% -2.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.108M $5.110M $5.100M
YoY Change 0.15% 0.2% 39.4%
Accrued Expenses $1.670M $1.670M $1.200M
YoY Change 39.17% 39.17% 26.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $247.1K $250.0K $315.1K
YoY Change -21.59% -21.88% -49.22%
Total Short-Term Liabilities $16.62M $16.62M $8.077M
YoY Change 105.78% 105.69% 31.86%
LONG-TERM LIABILITIES
Long-Term Debt $3.577M $3.580M $3.826M
YoY Change -6.52% -6.53% -7.65%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.577M $3.580M $3.826M
YoY Change -6.52% -6.53% -7.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.62M $16.62M $8.077M
Total Long-Term Liabilities $3.577M $3.580M $3.826M
Total Liabilities $20.20M $20.20M $11.90M
YoY Change 69.68% 69.75% 15.92%
SHAREHOLDERS EQUITY
Retained Earnings -$29.98M -$23.77M
YoY Change 26.14% 21.05%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock $58.98M $58.62M
YoY Change 0.62% 2.33%
Treasury Stock (at cost) $1.097M $122.2K
YoY Change 797.37%
Treasury Stock Shares 722.9K shares 67.10K shares
Shareholders Equity $28.90M $28.90M $35.73M
YoY Change
Total Liabilities & Shareholders Equity $49.10M $49.10M $47.63M
YoY Change 3.08% 3.09% -2.63%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income -$1.650M -$6.214M -$2.770M
YoY Change -40.43% 50.35% -5.14%
Depreciation, Depletion And Amortization $320.0K $1.284M $350.0K
YoY Change -8.57% -3.86% 9.38%
Cash From Operating Activities $70.00K $2.930M $1.360M
YoY Change -94.85% 1731.25% 166.67%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K $283.3K -$230.0K
YoY Change -65.22% -44.47% 27.78%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$80.00K -$280.0K -$230.0K
YoY Change -65.22% -45.1% 27.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $974.4K
YoY Change 697.37%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 360.0K -990.0K -180.0K
YoY Change -300.0% -254.69% -88.68%
NET CHANGE
Cash From Operating Activities 70.00K 2.930M 1.360M
Cash From Investing Activities -80.00K -280.0K -230.0K
Cash From Financing Activities 360.0K -990.0K -180.0K
Net Change In Cash 350.0K 1.660M 950.0K
YoY Change -63.16% 472.41% -175.4%
FREE CASH FLOW
Cash From Operating Activities $70.00K $2.930M $1.360M
Capital Expenditures -$80.00K $283.3K -$230.0K
Free Cash Flow $150.0K $2.647M $1.590M
YoY Change -90.57% -855.95% 130.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 rvp Revenue Recognition Overstock Return Period
RevenueRecognitionOverstockReturnPeriod
P12M
CY2013 rvp Revenue Recognition Maximum Percentage Of Distributors Total Purchase In Prior Twelve Month Period For Overstock Return
RevenueRecognitionMaximumPercentageOfDistributorsTotalPurchaseInPriorTwelveMonthPeriodForOverstockReturn
0.01 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1305847 shares
CY2013 rvp Revenue Recognition Overstock Return Limit Number
RevenueRecognitionOverstockReturnLimitNumber
2 item
CY2013 rvp Number Of Products Consigned To Customers
NumberOfProductsConsignedToCustomers
0 item
CY2012 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
36596 USD
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
10474 USD
CY2011 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
57000 USD
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P17Y
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1373345 shares
CY2013 rvp Number Of Significant Customers
NumberOfSignificantCustomers
2 item
CY2012 rvp Number Of Significant Customers
NumberOfSignificantCustomers
3 item
CY2011 rvp Number Of Significant Customers
NumberOfSignificantCustomers
4 item
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000 USD
CY2012Q4 rvp Allowance For Contractual Pricing
AllowanceForContractualPricing
3036564 USD
CY2013Q4 rvp Allowance For Contractual Pricing
AllowanceForContractualPricing
3611692 USD
CY2013 rvp Increase Decrease In Reserve For Non Contractual Rebates
IncreaseDecreaseInReserveForNonContractualRebates
0 USD
CY2013 rvp Revenue Recognition Period For Return Of Incorrect Shipments
RevenueRecognitionPeriodForReturnOfIncorrectShipments
P10D
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-6213852 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-4132892 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
1418482 USD
CY2013 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
916065 USD
CY2012 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
918108 USD
CY2011 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
964047 USD
CY2011 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-10120 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7129917 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5051000 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
454435 USD
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26999698 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26219728 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24171238 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26219728 shares
CY2011 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2101825 shares
CY2011 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
81723 shares
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3537872 USD
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26999698 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26354786 shares
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
52775 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1666525 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1692133 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4750459 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
6416984 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
5230005 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
681395 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
239752 USD
CY2012Q4 us-gaap Assets
Assets
47632158 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
4990253 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31081234 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30883668 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20171062 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18984018 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11899650 USD
CY2013 us-gaap Depreciation
Depreciation
1272770 USD
CY2012 us-gaap Depreciation
Depreciation
1264326 USD
CY2011 us-gaap Depreciation
Depreciation
1267813 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
179868 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2918929 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11479 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Accounting estimates</font></b></p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;">&#160;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Actual results could differ significantly from those estimates.</font></p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;">&#160;</p> </div>
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Concentration risks</font></b></p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;">&#160;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company&#8217;s financial instruments exposed to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable.&#160; Cash balances, some of which exceed federally insured limits, are maintained in financial institutions; however, Management believes the institutions are of high credit quality.&#160; The majority of accounts receivable are due from companies which are well-established entities.&#160; As a consequence, Management considers any exposure from concentrations of credit risks to be limited.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The following table reflects our significant customers in 2013, 2012, and 2011:</font></p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 24.5pt;">&#160;</p> <table style="text-align:left;WIDTH: 94.94%; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 27.35pt;" border="0" cellspacing="0" cellpadding="0" width="94%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 43.18%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="43%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Years&#160;Ended&#160;December&#160;31,</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="53%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2013</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2012</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2011</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Number of significant customers</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">4</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Aggregate dollar amount of net sales to significant customers</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$9.3 million</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$13.7 million</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$16.2 million</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 53.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="53%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Percentage of net sales to significant customers</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">30.2%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">40.6%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.64%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">50.6%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.06%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 24.5pt;">&#160;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Considering the current economic climate, the Company increased its allowance for doubtful accounts by approximately $50,000 this year.</font></p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;">&#160;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company manufactures syringes in Little Elm, Texas as well as utilizing manufacturers in China.&#160; The Company purchases most of its product components from single suppliers, including needle adhesives and packaging materials.&#160; There are multiple sources of these materials.&#160; The Company obtained roughly 72.9% of its finished products in 2013 from Double Dove, a Chinese manufacturer.&#160; Purchases from Double Dove aggregated 72.0% and 67.1% of finished products in 2012 and 2011, respectively.&#160; In the event that the Company becomes unable to purchase such product from Double Dove, the Company would need to find an alternate manufacturer for its 0.5mL insulin syringe, its 2mL, 5mL, and 10mL syringes and its autodisable syringe and increase domestic production for 1mL and 3mL syringes.</font></p> <p style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 27.35pt;">&#160;</p> </div>
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
219358 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
207879 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
275041 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
286520 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11479 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11479 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
11479 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
11479 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
11479 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71532 USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43934 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
3823996 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
315086 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3826210 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
247064 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
149742 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
159182 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
169211 USD
CY2013Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1720896 USD
CY2012Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1400740 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
169125 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
162969 USD
CY2013Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
84997 USD
CY2012Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
101961 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1665670 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
4141296 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
60401 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
59195 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
61607 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
62813 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
59966 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
122779 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
393343 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 rvp Preferred Stock Number Of Shares Exchanged Against Common Stock And Cash
PreferredStockNumberOfSharesExchangedAgainstCommonStockAndCash
1277464 shares
CY2011 rvp Stock Issued During Period Shares Exchanges
StockIssuedDuringPeriodSharesExchanges
1277464 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 rvp Accrued Dividends Eliminated
AccruedDividendsEliminated
3592659 USD
CY2013Q4 rvp Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Employee
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToEmployee
315711 USD
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
338253 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8837160 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
393343 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.029 pure
CY2011 rvp Amount Of Annual Dividend Reduction
AmountOfAnnualDividendReduction
450758 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
83470 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1785 USD
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-29070 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
7502 USD
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8033 USD
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
42867 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
90972 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9818 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13797 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90972 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9818 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13797 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3819961 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1350125 USD
CY2013Q4 rvp Deferred Tax Assets Liabilities Net Before Valuation
DeferredTaxAssetsLiabilitiesNetBeforeValuation
8443817 USD
CY2012Q4 rvp Deferred Tax Assets Liabilities Net Before Valuation
DeferredTaxAssetsLiabilitiesNetBeforeValuation
6039054 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6039054 USD
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1155638 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
35728996 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2404763 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8443817 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
83470 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4873433 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1165658 USD
CY2012Q4 rvp Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Employee
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToEmployee
295696 USD
CY2012Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
319830 USD
CY2012Q4 rvp Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Related To Non Employee
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRelatedToNonEmployee
15546 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6670163 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
631109 USD
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
631109 USD
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.029 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.029 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.393 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.280 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.012 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.020 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.003 pure
CY2013 rvp Effective Income Tax Rate Reconciliation Alternative Minimum Tax
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTax
-0.014 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.016 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.015 pure
CY2011 rvp Effective Income Tax Rate Reconciliation Return To Accrual Adjustments
EffectiveIncomeTaxRateReconciliationReturnToAccrualAdjustments
-0.028 pure
CY2011 rvp Effective Income Tax Rate Reconciliation Alternative Minimum Tax
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTax
0.034 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.110 pure
CY2011 rvp Effective Income Tax Rate Reconciliation Release Of Valuation Allowance Net Operating Loss Carryforward
EffectiveIncomeTaxRateReconciliationReleaseOfValuationAllowanceNetOperatingLossCarryforward
0.390 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002 pure
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.010 pure
CY2012 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
67102 shares
CY2013 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
655818 shares
CY2013 rvp Preferred Stock Number Of Classes Outstanding
PreferredStockNumberOfClassesOutstanding
1 item
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3476718 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
809592 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
783760 USD
CY2012Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
57613 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
35441064 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1065641 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
37907307 USD
CY2013 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20475170 USD
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4220809 USD
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
129107 USD
CY2012Q4 rvp Intangible Assets And Other Assets Noncurrent
IntangibleAssetsAndOtherAssetsNoncurrent
291444 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
49626 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
220268 USD
CY2011 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3439535 USD
CY2013Q4 us-gaap Assets
Assets
49097444 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
90972 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3576932 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8076952 USD
CY2012Q4 us-gaap Liabilities
Liabilities
11903162 USD
CY2013Q4 us-gaap Liabilities
Liabilities
20197456 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
USD
CY2012Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
58617308 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23767662 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
122202 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-4089833 USD
CY2012 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
46999 USD
CY2011 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
62596 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1210135 USD
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6158133 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 USD
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.88 pure
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
30785127 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
33644503 USD
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
32102296 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25963313 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5099884 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3694307 USD
CY2013Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
7724826 USD
CY2012Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9431 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47632158 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49097444 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27187702 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27252463 shares
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
19776198 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
18556257 USD
CY2012 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2691887 USD
CY2011 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2643209 USD
CY2012 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22468085 USD
CY2012 us-gaap Interest Expense
InterestExpense
231210 USD
CY2011 us-gaap Interest Expense
InterestExpense
240484 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
66867 USD
CY2012 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-30054 USD
CY2012 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
565231 USD
CY2011 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
5700000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6122880 USD
CY2011 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21199466 USD
CY2012 us-gaap Gross Profit
GrossProfit
11176418 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4123074 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1432279 USD
CY2011 us-gaap Gross Profit
GrossProfit
10902830 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
RETRACTABLE TECHNOLOGIES INC
CY2013 us-gaap Gross Profit
GrossProfit
10309957 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-5931245 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-3938863 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
871851 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
815018 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10022621 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10738110 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
16241202 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
15115281 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
14992663 USD
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000946563
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
19581725 USD
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27296312 shares
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1335858 USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
107246 USD
CY2012 us-gaap Inventory Write Down
InventoryWriteDown
120000 USD
CY2012 us-gaap Accretion Expense
AccretionExpense
3773 USD
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1311746 USD
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1298044 USD
CY2011 us-gaap Inventory Write Down
InventoryWriteDown
52835 USD
CY2011 us-gaap Accretion Expense
AccretionExpense
17610 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1127166 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2391937 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1305379 USD
CY2011 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
27454 USD
CY2011 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-462715 USD
CY2013 rvp Increase Decrease In Litigation Reserve
IncreaseDecreaseInLitigationReserve
7724826 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1441308 USD
CY2012 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
787393 USD
CY2012 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-29471 USD
CY2012 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-626219 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1054563 USD
CY2011 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-3646555 USD
CY2011 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-125529 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
826091 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-510117 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1620701 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
158337 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5513773 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25673263 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
122202 USD
CY2012 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
230450 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
510117 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-826091 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
641830 USD
CY2012 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
290050 USD
CY2011 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-612927 USD
CY2011 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
1357275 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54369 USD
CY2011 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
364625 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2280458 USD
CY2011 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
2407224 USD
CY2012 us-gaap Interest Paid
InterestPaid
264033 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
3474 USD
CY2011 us-gaap Interest Paid
InterestPaid
279691 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
188754 USD
CY2012 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
57613 USD
CY2011 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
534986 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1975018 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-282289 USD
CY2013 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
1666046 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
52775 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27629359 USD
CY2013 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23266039 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
38900501 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
38651452 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
28899988 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54369 USD
CY2011 us-gaap Dividends Preferred Stock
DividendsPreferredStock
364625 USD
CY2011 rvp Purchase Of Preferred Stock
PurchaseOfPreferredStock
1357275 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1620701 USD
CY2012 us-gaap Dividends Preferred Stock
DividendsPreferredStock
288063 USD
CY2012 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
122202 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
536925 USD
CY2013 us-gaap Dividends Preferred Stock
DividendsPreferredStock
230449 USD
CY2013 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
57613 USD
CY2013 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
974407 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
5735589 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10910172 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
247064 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1698506 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2186190 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
722920 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
67102 shares
CY2013 rvp Income Tax Expense Benefit Attributable To Carryback Losses
IncomeTaxExpenseBenefitAttributableToCarrybackLosses
10072410 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52775 USD
CY2013Q4 rvp Intangible Assets And Other Assets Noncurrent
IntangibleAssetsAndOtherAssetsNoncurrent
279965 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5107778 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
815044 USD
CY2013Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
57613 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
602209 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16620524 USD
CY2013Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
58983166 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29981514 USD
CY2013 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-9431 USD
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
281881 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7895 USD
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
787902 USD
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
90971 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2933569 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
283289 USD
CY2013 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-317303 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
536925 USD
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
974407 USD
CY2013 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
230449 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1096609 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
18000408 USD
CY2013 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2474762 USD
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4414339 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
837073 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10989790 USD
CY2013 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
38943 USD
CY2013 us-gaap Interest Expense
InterestExpense
230578 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1284249 USD
CY2013 us-gaap Inventory Write Down
InventoryWriteDown
530000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1275336 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-167589 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-985234 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
2929640 USD
CY2013 us-gaap Interest Paid
InterestPaid
241052 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
7988 USD

Files In Submission

Name View Source Status
0001104659-14-024455-index-headers.html Edgar Link pending
0001104659-14-024455-index.html Edgar Link pending
0001104659-14-024455.txt Edgar Link pending
0001104659-14-024455-xbrl.zip Edgar Link pending
a14-1080_110k.htm Edgar Link pending
a14-1080_1ex23.htm Edgar Link pending
a14-1080_1ex31d1.htm Edgar Link pending
a14-1080_1ex31d2.htm Edgar Link pending
a14-1080_1ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g10801bai001.gif Edgar Link pending
g10801bki001.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rvp-20131231.xml Edgar Link completed
rvp-20131231.xsd Edgar Link pending
rvp-20131231_cal.xml Edgar Link unprocessable
rvp-20131231_def.xml Edgar Link unprocessable
rvp-20131231_lab.xml Edgar Link unprocessable
rvp-20131231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending